标题
Alzheimer’s Disease: Lessons Learned from Amyloidocentric Clinical Trials
作者
关键词
Positron Emission Tomography, Mild Cognitive Impairment, Cerebral Amyloid Angiopathy, Target Engagement, Amyloid Precursor Protein Transgenic Mouse
出版物
CNS DRUGS
Volume 29, Issue 6, Pages 487-502
出版商
Springer Nature
发表日期
2015-07-17
DOI
10.1007/s40263-015-0257-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- 18F-Florbetapir PET in Patients with Frontotemporal Dementia and Alzheimer Disease
- (2015) C. Kobylecki et al. JOURNAL OF NUCLEAR MEDICINE
- Do current therapeutic anti-Aβ antibodies for Alzheimer’s disease engage the target?
- (2014) Andrew D. Watt et al. ACTA NEUROPATHOLOGICA
- Lessons from a BACE1 inhibitor trial: Off-site but not off base
- (2014) Debomoy K. Lahiri et al. Alzheimers & Dementia
- A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease
- (2014) Eric Karran et al. ANNALS OF NEUROLOGY
- Tauopathy contributes to synaptic and cognitive deficits in a murine model for Alzheimer's disease
- (2014) Ilie-Cosmin Stancu et al. FASEB JOURNAL
- Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects
- (2014) Robert Vassar et al. JOURNAL OF NEUROCHEMISTRY
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
- (2014) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Perspectives on future Alzheimer therapies: amyloid-β protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer’s disease
- (2014) Lars Lannfelt et al. Alzheimers Research & Therapy
- Active immunotherapy options for Alzheimer’s disease
- (2014) Bengt Winblad et al. Alzheimers Research & Therapy
- Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease
- (2014) Niklas Mattsson et al. Annals of Clinical and Translational Neurology
- Safety, tolerability and immunogenicity of an immunotherapeutic vaccine (vanutide cridificar [ACC-001]) and the QS-21 adjuvant in Japanese individuals with mild-to-moderate Alzheimer's disease: A phase IIa, multicenter, randomized, adjuvant and placebo clinical trial
- (2013) Heii Arai et al. Alzheimers & Dementia
- The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): Study design and progress
- (2013) Miia Kivipelto et al. Alzheimers & Dementia
- The therapeutics of Alzheimer's disease: Where we stand and where we are heading
- (2013) Dennis J. Selkoe ANNALS OF NEUROLOGY
- Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid
- (2013) Susan M. Landau et al. ANNALS OF NEUROLOGY
- A Population-Based Clinicopathological Study in the Oldest-Old: The 90+ Study
- (2013) Maria M. Corrada et al. Current Alzheimer Research
- [18F]Flutemetamol amyloid-beta PET imaging compared with [11C]PIB across the spectrum of Alzheimer’s disease
- (2013) Shizuo Hatashita et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- AZD1080, a novel GSK3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans
- (2013) Biljana Georgievska et al. JOURNAL OF NEUROCHEMISTRY
- Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
- (2013) Victor L Villemagne et al. LANCET NEUROLOGY
- Alzheimer disease therapy—moving from amyloid-β to tau
- (2013) Ezio Giacobini et al. Nature Reviews Neurology
- Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer's disease
- (2013) David J. Irwin et al. Frontiers in Aging Neuroscience
- Passive anti-amyloid immunotherapy in Alzheimer's disease: What are the most promising targets?
- (2013) Jens Moreth et al. Immunity & Ageing
- Amyloid-β–Associated Clinical Decline Occurs Only in the Presence of Elevated P-tau
- (2012) Rahul S. Desikan et al. ARCHIVES OF NEUROLOGY
- Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease
- (2012) Vladimir Coric et al. ARCHIVES OF NEUROLOGY
- A contrast in safety, pharmacokinetics and pharmacodynamics across age groups after a single 50 mg oral dose of the γ-secretase inhibitor avagacestat
- (2012) Gary Tong et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Effects of Single Doses of Avagacestat (BMS-708163) on Cerebrospinal Fluid Aβ Levels in Healthy Young Men
- (2012) Gary Tong et al. CLINICAL DRUG INVESTIGATION
- A Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Avagacestat (BMS-708163) in Healthy Young and Elderly Subjects
- (2012) Randy Dockens et al. CLINICAL PHARMACOKINETICS
- The mechanism of γ-Secretase dysfunction in familial Alzheimer disease
- (2012) Lucía Chávez-Gutiérrez et al. EMBO JOURNAL
- Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons
- (2012) Peer-Hendrik Kuhn et al. EMBO JOURNAL
- Solanezumab for the treatment of mild-to-moderate Alzheimer’s disease
- (2012) Bruno P Imbimbo et al. Expert Review of Clinical Immunology
- Phase I Pharmacologic and Pharmacodynamic Study of the Gamma Secretase (Notch) Inhibitor MK-0752 in Adult Patients With Advanced Solid Tumors
- (2012) Ian Krop et al. JOURNAL OF CLINICAL ONCOLOGY
- An Effector-Reduced Anti- -Amyloid (A ) Antibody with Unique A Binding Properties Promotes Neuroprotection and Glial Engulfment of A
- (2012) O. Adolfsson et al. JOURNAL OF NEUROSCIENCE
- Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study
- (2012) Christopher M Clark et al. LANCET NEUROLOGY
- The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
- (2012) Iryna Benilova et al. NATURE NEUROSCIENCE
- A Plaque-Specific Antibody Clears Existing β-amyloid Plaques in Alzheimer's Disease Mice
- (2012) Ronald B. DeMattos et al. NEURON
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab
- (2011) Susanne Ostrowitzki ARCHIVES OF NEUROLOGY
- Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease
- (2011) P. Hemachandra Reddy BRAIN RESEARCH
- γ-Secretase modulators do not induce Aβ-rebound and accumulation of β-C-terminal fragment
- (2011) Ting Li et al. JOURNAL OF NEUROCHEMISTRY
- Robust Central Reduction of Amyloid- in Humans with an Orally Available, Non-Peptidic -Secretase Inhibitor
- (2011) P. C. May et al. JOURNAL OF NEUROSCIENCE
- Functional network disruption in the degenerative dementias
- (2011) Michela Pievani et al. LANCET NEUROLOGY
- The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
- (2011) Eric Karran et al. NATURE REVIEWS DRUG DISCOVERY
- Soluble amyloid -protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration
- (2011) M. Jin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Single Ascending Dose Study of Bapineuzumab in Patients With Alzheimer Disease
- (2010) Ronald S. Black et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Revising the definition of Alzheimer's disease: a new lexicon
- (2010) Bruno Dubois et al. LANCET NEUROLOGY
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
- (2010) Kaj Blennow et al. Nature Reviews Neurology
- Decreased Clearance of CNS -Amyloid in Alzheimer's Disease
- (2010) K. G. Mawuenyega et al. SCIENCE
- The culprit behind amyloid beta peptide related neurotoxicity in Alzheimer's disease: oligomer size or conformation?
- (2010) Kerensa Broersen et al. Alzheimers Research & Therapy
- Prevention of Dementia by Intensive Vascular Care (PreDIVA)
- (2009) Edo Richard et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Long-Term Follow-Up of Patients Immunized with AN1792: Reduced Functional Decline in Antibody Responders
- (2009) Bruno Vellas et al. Current Alzheimer Research
- Angiogenesis: A Team Effort Coordinated by Notch
- (2009) L.-K. Phng et al. DEVELOPMENTAL CELL
- Cerebrospinal fluid tau and ptau181increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease
- (2009) Anne M. Fagan et al. EMBO Molecular Medicine
- Total and phosphorylated tau protein as biological markers of Alzheimer’s disease
- (2009) Harald Hampel et al. EXPERIMENTAL GERONTOLOGY
- Development of semagacestat (LY450139), a functional γ-secretase inhibitor, for the treatment of Alzheimer's disease
- (2009) David B Henley et al. EXPERT OPINION ON PHARMACOTHERAPY
- Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer DiseaseA Randomized Controlled Trial
- (2009) Robert C. Green JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
- (2009) Clifford R Jack et al. LANCET NEUROLOGY
- Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies
- (2009) Kurt R. Brunden et al. NATURE REVIEWS DRUG DISCOVERY
- A novel pathway for amyloid precursor protein processing
- (2009) Erik Portelius et al. NEUROBIOLOGY OF AGING
- A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
- (2009) S. Salloway et al. NEUROLOGY
- Identification of β-Secretase (BACE1) Substrates Using Quantitative Proteomics
- (2009) Matthew L. Hemming et al. PLoS One
- Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship
- (2008) Peter T. Nelson et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Amyloid-β immunisation for Alzheimer's disease
- (2008) Thomas Wisniewski et al. LANCET NEUROLOGY
- Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial
- (2008) Gordon K Wilcock et al. LANCET NEUROLOGY
- Antibody Capture of Soluble Aβ Does Not Reduce Cortical Aβ Amyloidosis in the PDAPP Mouse
- (2008) Peter Seubert et al. Neurodegenerative Diseases
- Progress in the Active Immunotherapeutic Approach to Alzheimer’s Disease: Clinical Investigations into AN1792-Associated Meningoencephalitis
- (2008) Michael Pride et al. Neurodegenerative Diseases
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started